CTMC / A joint venture between Resilience + MD Anderson Cancer Center
Subhashini Ramgopal is an Associate III at CTMC, previously working as an Associate II at Catalent Pharma Solutions. Prior to that, Subhashini was a Research Assistant at Duke-NUS Medical School, focusing on identifying and analyzing novel genetic mutations in seminomas. Subhashini also has experience as a Lecturer at Punjab Technical University, a Research Intern at Defence Research and Development Organisation working on fMRI applications for mapping human emotions, and a Summer Intern at Jawaharlal Nehru University studying Helicobactor pylori’s pre-initiation complex proteins. Subhashini holds a Master of Science in Biochemical Engineering from UCL and a Bachelor of Technology in Biotechnology from Uttar Pradesh Technical University.
This person is not in any offices
CTMC / A joint venture between Resilience + MD Anderson Cancer Center
Cell Therapy Manufacturing Center (CTMC) is a joint venture between Resilience and MD Anderson Cancer Center. CTMC was created to bring together the leading complex biologics manufacturing technology organization and the #1 clinical cancer center to enable innovation from academia and biotech to accelerate Cell Therapy’s impact for cancer patients.
Employees
51-200